Inventiva IVA
NASDAQ IVA
$4.01 +0.06 (+1.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Inventiva (IVA) Return on Capital Employed [ROCE] (2021)

Updated

Inventiva (IVA) reported Return on Capital Employed [ROCE] of -231.49% for FY2025.

Analysis

Inventiva (IVA) Return on Capital Employed [ROCE] (2021) Analysis & Trends

Dating back to FY2019, Inventiva's Return on Capital Employed [ROCE] record includes 6 years.

  • Return on Capital Employed [ROCE] has a five-year change of -195.89 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual Return on Capital Employed [ROCE] since FY2022.
  • According to Business Quant data, Return on Capital Employed [ROCE] came in at -259.22% in FY2023 (-200.97 pp), -58.25% in FY2022 (-8.69 pp) and -49.56% in FY2021 (-13.96 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Inventiva 763.29 Mn 38.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -35.29%
API Access

Inventiva Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IVA&period=max&api_key=YOUR_API_KEY